Patient Guide: A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 27 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06953583
Status: 🟢 Enrolling Now
Condition: Friedreich Ataxia
Phase: PHASE3

Where You Can Participate

This study is available at 27 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Gainesville, Florida
  • • Tampa, Florida
  • • And 24 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old - Join Clinical Trial NCTNCT06953583

How to Join This Clinical Trial - NCTNCT06953583

Learn how to participate in this PHASE3 trial studying an investigational therapy for Friedreich Ataxia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Friedreich Ataxia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Friedreich Ataxia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06953583 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 27 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90095 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Gainesville, Florida 32608-3928 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: RECRUITING

Clinical Research Site

Memphis, Tennessee 38105-3678 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Norfolk, Virginia 23507-1910 - United States

Status: RECRUITING

Clinical Research Site

Parkville, Victoria 3052 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Innsbruck, 6020 - Austria

Status: NOT_YET_RECRUITING

Clinical Research Site

Brasília, Federal District 70200-730 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Campinas, São Paulo 13083-970 - Brazil

Status: NOT_YET_RECRUITING

And 17 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Friedreich Ataxia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships